Walgreens Boots Alliance (WBA) Price Target Raised to $76.00 at Citigroup

Walgreens Boots Alliance (NASDAQ:WBA) had its target price raised by Citigroup from $69.00 to $76.00 in a report released on Friday morning. They currently have a neutral rating on the pharmacy operator’s stock.

A number of other equities analysts also recently weighed in on WBA. Zacks Investment Research upgraded Walgreens Boots Alliance from a hold rating to a buy rating and set a $81.00 target price on the stock in a research note on Tuesday, September 25th. ValuEngine upgraded Walgreens Boots Alliance from a strong sell rating to a sell rating in a research note on Friday, September 21st. Robert W. Baird boosted their target price on Walgreens Boots Alliance from $64.00 to $69.00 and gave the stock a neutral rating in a research note on Tuesday, September 11th. Cowen downgraded Walgreens Boots Alliance from an outperform rating to a market perform rating and set a $104.00 target price on the stock. in a research note on Monday, July 23rd. Finally, BidaskClub upgraded Walgreens Boots Alliance from a hold rating to a buy rating in a research note on Wednesday, September 12th. One research analyst has rated the stock with a sell rating, eleven have assigned a hold rating, seven have issued a buy rating and two have assigned a strong buy rating to the company’s stock. Walgreens Boots Alliance presently has a consensus rating of Hold and an average target price of $77.56.

Shares of WBA opened at $73.50 on Friday. The company has a debt-to-equity ratio of 0.44, a current ratio of 0.93 and a quick ratio of 0.47. The company has a market cap of $72.35 billion, a price-to-earnings ratio of 14.41, a P/E/G ratio of 1.11 and a beta of 1.04. Walgreens Boots Alliance has a 52 week low of $59.07 and a 52 week high of $80.68.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings data on Thursday, October 11th. The pharmacy operator reported $1.48 EPS for the quarter, topping analysts’ consensus estimates of $1.45 by $0.03. The firm had revenue of $33.44 billion during the quarter, compared to analyst estimates of $33.64 billion. Walgreens Boots Alliance had a return on equity of 21.22% and a net margin of 3.36%. Analysts expect that Walgreens Boots Alliance will post 5.98 EPS for the current year.

In related news, Director William C. Foote sold 2,736 shares of the company’s stock in a transaction that occurred on Thursday, August 2nd. The stock was sold at an average price of $65.99, for a total value of $180,548.64. Following the transaction, the director now owns 10,943 shares in the company, valued at $722,128.57. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. 14.80% of the stock is currently owned by corporate insiders.

A number of institutional investors have recently bought and sold shares of the stock. Parkside Financial Bank & Trust lifted its stake in Walgreens Boots Alliance by 10.1% in the third quarter. Parkside Financial Bank & Trust now owns 7,649 shares of the pharmacy operator’s stock valued at $557,000 after purchasing an additional 703 shares during the last quarter. Hugh Johnson Advisors LLC lifted its stake in Walgreens Boots Alliance by 11.0% in the second quarter. Hugh Johnson Advisors LLC now owns 7,801 shares of the pharmacy operator’s stock valued at $468,000 after purchasing an additional 773 shares during the last quarter. World Asset Management Inc lifted its position in shares of Walgreens Boots Alliance by 1.4% during the second quarter. World Asset Management Inc now owns 58,572 shares of the pharmacy operator’s stock worth $3,515,000 after acquiring an additional 807 shares in the last quarter. Busey Trust CO lifted its position in shares of Walgreens Boots Alliance by 8.1% during the third quarter. Busey Trust CO now owns 10,824 shares of the pharmacy operator’s stock worth $789,000 after acquiring an additional 812 shares in the last quarter. Finally, BDO Wealth Advisors LLC lifted its position in shares of Walgreens Boots Alliance by 11.1% during the second quarter. BDO Wealth Advisors LLC now owns 8,411 shares of the pharmacy operator’s stock worth $505,000 after acquiring an additional 837 shares in the last quarter. Institutional investors and hedge funds own 61.92% of the company’s stock.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of general merchandise, including non-prescription drugs, beauty products, photo finishing, seasonal merchandise, greeting cards, and convenience foods through its retail drugstores and convenient care clinics.

Further Reading: Dividend Aristocrat Index

Analyst Recommendations for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply